Ambulatory blood pressure monitoring in
β
T. Tsuchihashi; A. Tsukashima; K. Matsumura; I. Abe; M. Tominaga; Y. Nakao; K. K
π
Article
π
1991
π
Springer
π
English
β 210 KB
A newly developed calcium antagonist, nilvadipine, was administered to 7 hypertensive patients aged 75.6 y. Nilvadipine 4 mg b.d. decreased the average 24-h blood pressure significantly from 169/89 mmHg to 152/81 mmHg after 7 to 14 days without any change in the pulse rate. The circadian patterns of